HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Clinical and cell kinetic studies of the effects of the epipodophyllotoxin VP16-213 during therapy of refractory acute nonlymphocytic leukemia.

AuthorsA T Look, G V Dahl, G Rivera, A M Mauer
JournalCancer chemotherapy and pharmacology (Cancer Chemother Pharmacol) Vol. 7 Issue 2-3 Pg. 161-7 ( 1982) ISSN: 0344-5704 [Print] Germany
PMID6177437 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • DNA, Neoplasm
  • Etoposide
  • Podophyllotoxin
  • Azacitidine
Topics
  • Acute Disease
  • Adolescent
  • Adult
  • Azacitidine (therapeutic use)
  • Cell Division (drug effects)
  • Child
  • Child, Preschool
  • DNA, Neoplasm (metabolism)
  • Drug Resistance
  • Etoposide (administration & dosage, therapeutic use)
  • Female
  • Flow Cytometry
  • Humans
  • Infant
  • Kinetics
  • Leukemia (drug therapy, pathology)
  • Male
  • Mitosis (drug effects)
  • Podophyllotoxin (analogs & derivatives)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: